Treatment With MK6592 and an Anti-cancer Drug in Patients With Advanced Solid Tumors (6592-001)
Clinical trial NCT00359671 · TERMINATED
Trial details
- NCT number
- NCT00359671
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2007-07-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.